These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24924311)

  • 1. Comparison of the pharmacokinetics of linezolid in burn and non-burn rabbits.
    Ma JL; Gao L; Li X; Chu WL; Feng YQ; Wang XQ; Zhang QZ
    Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):355-61. PubMed ID: 24924311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
    Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
    J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in patients with severe burn injuries.
    Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
    Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
    Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
    Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?
    Corcione S; D'Avolio A; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Romeo M; Di Perri G; Stella M; De Rosa FG
    J Glob Antimicrob Resist; 2020 Mar; 20():22-27. PubMed ID: 31207380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of linezolid in critically ill patients.
    Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis.
    Hallam MJ; Allen JM; James SE; Donaldson PM; Davies JG; Hanlon GW; Dheansa BS
    J Burn Care Res; 2010; 31(1):207-9. PubMed ID: 20061858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of Linezolid in burn patients.
    Mokline A; Gharsallah L; Rahmani I; Gaies E; Tabelsi S; Messadi AA
    Ann Burns Fire Disasters; 2018 Jun; 31(2):118-121. PubMed ID: 30374263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic variability of extended interval tobramycin in burn patients.
    Bracco D; Landry C; Dubois MJ; Eggimann P
    Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics differences of propofol during different pathological stages of severe burn in rabbits].
    Hu QG; Hao JH; Chai JK; Yang HM; Sun XF; Li P; Li MM; Liu S
    Zhonghua Shao Shang Za Zhi; 2010 Feb; 26(1):37-40. PubMed ID: 20510032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.
    Villa G; Cassetta MI; Tofani L; Valente S; Chelazzi C; Falsini S; De Gaudio AR; Novelli A; Ronco C; Adembri C
    Int J Antimicrob Agents; 2015 Oct; 46(4):465-8. PubMed ID: 26315198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury.
    Mohr JF; Ostrosky-Zeichner L; Wainright DJ; Parks DH; Hollenbeck TC; Ericsson CD
    Antimicrob Agents Chemother; 2008 May; 52(5):1891-3. PubMed ID: 18299410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of linezolid for methicillin-resistant Staphylococcus aureus pneumonia in an adult receiving extracorporeal membrane oxygenation.
    Nikolos P; Osorio J; Mohrien K; Rose C
    Am J Health Syst Pharm; 2020 May; 77(11):877-881. PubMed ID: 32426841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?
    Baldelli S; Montrasio C; Cheli S; Viganò O; Bini T; Egidi M; Cattaneo D
    Ther Drug Monit; 2020 Apr; 42(2):347-348. PubMed ID: 32195990
    [No Abstract]   [Full Text] [Related]  

  • 19. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment.
    Gomez DS; Sanches-Giraud C; Silva CV; Oliveira AM; da Silva JM; Gemperli R; Santos SR
    J Antibiot (Tokyo); 2015 Mar; 68(3):143-7. PubMed ID: 25227503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study.
    Wicha SG; Frey OR; Roehr AC; Pratschke J; Stockmann M; Alraish R; Wuensch T; Kaffarnik M
    Int J Antimicrob Agents; 2017 Oct; 50(4):557-563. PubMed ID: 28711678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.